|
|
Provectus Granted China Patent for Imaging Drug
publication date: Feb 27, 2008
Provectus Pharmaceuticals, Inc. was granted patents in China and Europe for the use of PV-10 as an imaging agent for CT and MRI scans. PV-10, which is commonly known as Rose Bengal, was given the patent as an imaging agent for diagnosis of cancer. However, the use of PV-10 as an imaging agent is less important to Provectus than use of the drug as a treatment for cancer and dermatological conditions. Clinical trials for both indications are in progress. More details...
Stock Symbol: (OTCBB: PVCT)
|
ChinaBio® Events
ChinaBio® Partnering Forum 2012May 23-24, 2012 Suzhou, China >>More events...
Partner Events
 China Healthcare Investment Conference 2012March 13-15, 2012 Shanghai, China Shanghai CEO ConferenceMarch 28-29, 2012 Shanghai, China >>More details...
Other Events
China Pharmaceutical R&D SummitApril 23-26, 2012 Shanghai, China Biosimilars Asia 2012April 23-26, 2012 Shanghai, China Vaccines China 2012April 23-26, 2012 Shanghai, China
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners
![]()
|